Press Releases

September 27, 2012 Lupin receives FDA approval for its Oral Contraceptive VyfemlaTM Tablets Generic of Ovcon® 35 Tablets

September 13, 2012 Lupin receives FDA approval for Generic Lexapro® Tablets e® Tablets

July 24, 2012 Record Sales & Profits Net Sales up 44%, PBT up 67%, PAT up 33% Quarter I Results, FY 2012-13

July 6, 2012 Ernst & Young announces Lupin Pharmaceuticals Inc., CEO Vinita Gupta as Entrepreneur of the Year, Maryland – 060712

June 5, 2012 Lupin receives FDA approval for SUPRAX® (Cefixime) Capsules, 400 mg NDA Approval to add to growing SUPRAX® Franchise ®

May 15, 2012 Lupin Launches Generic Combivir® Tablets

May 10, 2012 Lupin Sales and Operating Profit up 22%

April 24, 2012 Lupin To Set Up New Formulations Manufacturing Facility In MIHAN

April 19, 2012 Lupin Resumes Sales of Generic Fortamet®